Thomas A. Shea Joins EPIRUS Biopharmaceuticals as Chief Financial Officer

Published: Jun 18, 2013

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

BOSTON--(BUSINESS WIRE)--EPIRUS Biopharmaceuticals, Inc. (EPIRUS), a privately held biotechnology company focused on the development and production of biosimilar products in and for major emerging markets, today announced the appointment of Thomas Shea as Chief Financial Officer (CFO).

Help employers find you! Check out all the jobs and post your resume.

Back to news